Panc 05.04 Cells

The Panc 05.04 cell line is a pancreatic ductal adenocarcinoma (PDAC) model that serves as a valuable resource for studying pancreatic cancer biology and therapeutic responses. Originating from a human pancreatic carcinoma, Panc 05.04 represents a critical tool in preclinical research due to its relevance to one of the most aggressive malignancies with poor patient outcomes. This cell line displays molecular and genomic characteristics that align with the heterogeneous nature of PDAC, including mutations commonly observed in KRAS, TP53, and other driver oncogenes that are prevalent in pancreatic cancer progression. Panc 05.04 has been extensively profiled as part of large-scale genomic initiatives, such as the Cancer Cell Line Encyclopedia (CCLE), where its gene expression, copy number variations, and drug sensitivity have been characterized. Notably, Panc 05.04 has been assessed for its pharmacological response to various anticancer agents, offering insights into its sensitivity or resistance profiles to chemotherapy and targeted therapies. As a model system, Panc 05.04 facilitates investigations into the molecular mechanisms underlying PDAC progression, chemoresistance, and tumor microenvironment interactions. It also provides a platform for testing emerging targeted therapies and immunotherapeutic strategies aimed at overcoming the refractory nature of pancreatic cancers.